Inactief instrument

Andere talen Lansen Pharmaceutical Holdings Limited

Aandelen

503 KYG5380M1033

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Lansen Pharmaceutical to Delist from HKEX on Dec. 19	18/12
Cayman Islands Court Approves Takeover, Privatization of Lansen Pharma	15/12
Cathay International Holdings Limited completed the acquisition of additional 31.78% stake in Lansen Pharmaceutical Holdings Limited.	15/12
Cathay International Pharma to Privatize Lansen Pharmaceutical in HK$239 Million Deal	18-09-23
Lansen Pharmaceutical's H1 Profit Slides 17%	25-08-23
Lansen Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	24-08-23
Lansen Pharmaceutical Holdings Limited commences an Equity Buyback Plan for 42,243,243 shares, representing 10% of its issued share capital, under the authorization approved on June 21, 2023.	23-06-23
Lansen Pharmaceutical Holdings Limited's Equity Buyback announced on June 24, 2022, has expired.	21-06-23
Tranche Update on Lansen Pharmaceutical Holdings Limited's Equity Buyback Plan announced on June 24, 2022.	24-03-23
Lansen Pharmaceutical Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	24-03-23
Lansen Pharmaceutical Holdings Limited Declares Interim Dividend	24-03-23
Lansen Pharmaceutical Expects 2022 Profit Soaring 798%; Shares Surge 22%	16-01-23
Lansen Pharmaceutical Holdings Limited Provides Earnings Guidance for the Twelve Months Ended 31 December 2022	16-01-23
Lansen Pharmaceutical Holdings Limited Appoints Zhu Xun as Independent Non-Executive Director and Member of the Remuneration Committee	23-09-22
Tranche Update on Lansen Pharmaceutical Holdings Limited's Equity Buyback Plan announced on June 24, 2022.	31-08-22
Lansen Pharmaceutical Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022	31-08-22
Lansen Pharmaceutical Holdings Limited commences an Equity Buyback Plan for 42,683,400 shares, representing 10% of its issued share capital, under the authorization approved on June 23, 2022.	24-06-22
Lansen Pharmaceutical Holdings Limited Approves to Elect Chan Ching Har, Eliza as an Independent Non-Executive Director	23-06-22
Lansen Pharmaceutical Holdings Limited's Equity Buyback announced on June 2, 2021, has expired.	23-06-22
Lansen Pharma Sees Better Financial Performance in H1	15-06-22

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Lansen Pharmaceutical Holdings Limited

Aandelen

503

KYG5380M1033

Andere talen

Filters